This is a routine initial ownership filing by a new insider. No trading signal. Monitor for future Form 4 filings to track any subsequent open-market purchases or sales by this insider.
TAK drugs
TAK drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 6 $16.89entry
- T+1 · 4mo ago +0.41%α +0.89% · $16.96
- T+5 · 4mo ago −1.95%α −2.44% · $16.56
- T+20 · 4mo ago +1.18%α +1.75% · $17.09
- T+60 · 7w ago +9.59%α +7.68% · $18.51
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Bruce Broussard filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 795 American Depositary Shares in Takeda Pharmaceutical Co Ltd. The filing also includes a power of attorney authorizing legal counsel to execute future Section 16 filings. This is a routine administrative filing by a new insider and has no material impact on the company's operations or financials.
Key Facts
- Bruce Broussard filed a Form 3 initial statement of beneficial ownership
- Reports beneficial ownership of 795 American Depositary Shares in Takeda Pharmaceutical Co Ltd
- Filing includes a power of attorney for Section 16 and Rule 144 filings
- No material financial data, guidance, or operational changes disclosed
Financial Impact
No material financial impact; 795 ADS stake is negligible relative to Takeda's $2.4B market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001395064-26-000240 |
| Document: 0001395064-26-000240-index-headers.html | 0001395064-26-000240 |
| Document: 0001395064-26-000240-index.html | 0001395064-26-000240 |
| Document: 0001395064-26-000240.txt | 0001395064-26-000240 |
Track record
18 reports on TAK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $21.19 to $21.12 Now $21.59 +1.89% ▼ −0.33% −3.62% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 30, 202617d ago 144 Neutral 2/10 Entry $20.87 to $21.09 Now $21.59 +3.45% ▲ +1.05% +0.98% vs SPY
- Oct 29, 202618d ago 6-K Neutral 4/10 No price data
- Oct 29, 202618d ago 6-K Bearish 5/10 Entry $20.01 to $21.19 Now $21.59 −7.90% ▼ −5.90% −10.62% vs SPY
- Sep 14, 20269w ago 6-K Bullish 7/10 Entry $18.60 to $18.89 Now $21.59 +16.08% ▲ +1.56% +1.45% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $18.24 to $17.98 Now $21.59 +18.37% ▼ −1.43% −1.89% vs SPY
- Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $18.13 to $18.03 Now $21.59 +19.08% ▼ −0.55% −1.67% vs SPY
- Aug 14, 202613w ago Court Ruling Neutral 4/10 Entry $17.38 to $18.24 Now $21.59 +24.22% ▲ +4.95% +6.14% vs SPY
- Aug 12, 202613w ago Insider Cluster Neutral 3/10 Entry $17.39 to $18.13 Now $21.59 +24.15% ▲ +4.26% +6.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers